A combination of mRNA and a new lipid nanoparticle could help heal damaged lungs, according to new research from the Perelman ...

A combination of mRNA and a new lipid nanoparticle could help heal damaged lungs, according to new research from the Perelman ...

HealthDay News — For patients with BRAF V600E-mutant metastatic colorectal cancer (mCRC), encorafenib + cetuximab (EC) plus standard chemotherapy (modified folinic acid [or levofolinate], fluorouracil ...

A new case report details a novel genetic mutation linked to drug resistance in a non-small cell lung cancer patient ... This specific genetic alteration made his cancer susceptible to lorlatinib, a ...

People have practiced ozone therapy in medical settings for many years. However, its use is now controversial amid safety concerns. The Food and Drug Administration (FDA) has warned against using ...

The AI-driven tools are getting better at recommending biomarker-targeted therapies, but experts warn they aren't ready for prime time.

Interferon beta injectable drugs were the first DMTs approved for MS treatment. The injections help change the course of active relapsing-remitting MS and secondary progressive MS. If a person has ...

TUESDAY, Feb. 4, 2025 (HealthDay News) -- For patients with BRAF V600E-mutant metastatic colorectal cancer (mCRC), encorafenib + cetuximab (EC) plus standard chemotherapy (modified folinic acid [or ...

Pfizer Inc. (NYSE: PFE) today announced positive topline results from the progression-free survival (PFS) analysis of the Phase 3 BREAKWATER study of ...

For lung cancer, we are in the process of shifting to immunotherapy and targeted therapy based on gene panel tests. It has improved the survival rate and period, as well as the patients' quality ...